Robert F. Kennedy Jr. has been appointed head of the US Department of Health and Human Services, raising concerns due to his history of promoting vaccine misinformation. He plans to prioritize chronic illness and nutrition but has deprioritized research on infectious diseases, alarming public health experts who warn that this could hinder responses to outbreaks like avian influenza. Meanwhile, researchers have made breakthroughs in enzyme design using AI, creating enzymes that excel in multi-step reactions, albeit still less effective than natural counterparts. The scientific community is also addressing Elon Musk's controversial role within the Royal Society.
Kennedy's appointment raises concerns regarding his focus on chronic illness and nutrition, potentially neglecting the critical connections between infectious diseases and public health.
AI-designed enzymes have proven to be 60,000 times more effective than their predecessors in accelerating serine hydrolysis, crucial for industrial and biological processes.
As Kennedy deprioritizes infectious disease research, experts warn that this shift might weaken the US response to ongoing health challenges like H5N1 avian influenza.
Fellows of the Royal Society express alarm over Musk's membership, pointing out his social-media behavior and actions that apparently contradict the institution's standards for scientific conduct.
Collection
[
|
...
]